Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "P01A" (17)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Metronidazole (P01AB01) 13 products
WHO-DDD
DrugBank.ca
IP
CI
Flagyl 250 mg
20 Tablet(s)
4.01
13.55
10 %
Coated tablets: Metronidazolum 250 mg
Labatec Pharma SA
B / SL / SO
FB
G
IP
CI
Flagyl 500 mg
‐
I
-
T
4 Tablet(s)
1.51
10.85
20 %
Coated tablets: Metronidazolum 500 mg
Labatec Pharma SA
B / SL / SO
FB
G
IP
CI
Flagyl 500 mg
-
T
20 Tablet(s)
6.70
16.50
20 %
Coated tablets: Metronidazolum 500 mg
Labatec Pharma SA
B / SL / SO
FB
G
IP
CI
CM
Metronidazole Zentiva 250 mg
20 Tablet(s)
3.10
12.60
10 %
Coated tablets: Metronidazolum 250 mg
Helvepharm AG
●
B / SL / SG
FB
G
IP
CI
CM
Metronidazole Zentiva 500 mg
4 Tablet(s)
1.22
10.55
10 %
Coated tablets: Metronidazolum 500 mg
Helvepharm AG
●
B / SL / SG
FB
G
IP
CI
CM
Metronidazole Zentiva 500 mg
20 Tablet(s)
5.43
15.15
10 %
Coated tablets: Metronidazolum 500 mg
Helvepharm AG
●
B / SL / SG
FB
G
IP
CI
Metrolag 250 mg
20 Tablet(s)
3.02
12.50
10 %
Tablets: Metronidazolum 250 mg
Lagap SA
B / SL / SG
FB
G
IP
CI
Metrolag 500 mg
8 Tablet(s)
2.21
11.65
10 %
Tablets: Metronidazolum 500 mg
Lagap SA
B / SL / SG
FB
G
IP
CI
Metrolag 500 mg
24 Tablet(s)
6.52
16.30
10 %
Tablets: Metronidazolum 500 mg
Lagap SA
B / SL / SG
FB
G
IP
CI
Metrolag 250 mg
100 Tablet(s)
k.A.
Tablets: Metronidazolum 250 mg
Lagap SA
B
FB
G
IP
CI
Metrolag 500 mg
100 Tablet(s)
k.A.
Tablets: Metronidazolum 500 mg
Lagap SA
B
FB
G
CI
Rivozol 250 mg
20 Tablet(s)
k.A.
Tablets: Metronidazolum 250 mg
Rivopharm SA
B
FB
G
IP
CI
Rivozol
60 ml
k.A.
Suspension (oral): 2 Active Agents
Rivopharm SA
B
FB
G
Ornidazole (P01AB03) 3 products
WHO-DDD
IP
CI
Tiberal 500 mg
10 Tablet(s)
13.78
31.40
10 %
Coated tablets: Ornidazolum 500 mg
Curatis AG
B / SL
FB
G
IP
CI
Tiberal 500 mg/3 mL
5 ampoule(s)
k.A.
Concentrate for infusion: Ornidazolum 500mg / 3ml
Curatis AG
B
FB
G
IP
CI
Tiberal 1 g/6 mL
5 ampoule(s)
k.A.
Concentrate for infusion: Ornidazolum
Curatis AG
B
FB
G
Atovaquone (P01AX06) 1 products
WHO-DDD
DrugBank.ca
L
IP
CI
Wellvone
210 ml
379.91
429.60
10 %
Suspension: Atovaquonum 750mg / 5ml
GlaxoSmithKline AG
A / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
